ARK Invest · #1 of 6
Cathie Wood
Disruptive innovation: autonomy, genomics, fintech.
- Since filing
- +6.4%
- S&P 500
- −3.4%
- vs S&P 500
- +9.8%
Q2 2026 13F, holdings as of Jun 30, 2026, public Aug 14, 2026. See the filing
| Position | Weight | At filing | Now | Since filing |
|---|---|---|---|---|
| TSLA Tesla | 7.5% | $342.27 | $379.78 | +11.0% |
| AMD Advanced Micro Devices | 5.3% | $514.39 | $515.21 | +0.2% |
| SPCX SpaceX | 5.0% | $140.00 | $143.09 | +2.2% |
| TEM Tempus AI | 3.8% | $52.10 | $80.54 | +54.6% |
| HOOD Robinhood | 3.4% | $95.56 | $81.33 | −14.9% |
| CRSP CRISPR Therapeutics | 3.4% | $53.55 | $45.15 | −15.7% |
| SHOP Shopify | 3.1% | $154.32 | $146.61 | −5.0% |
| TWST Twist Bioscience | 3.0% | $118.57 | $132.13 | +11.4% |
| TXG 10x Genomics | 2.5% | $56.09 | $62.90 | +12.1% |
| AMZN Amazon | 2.5% | $262.65 | $270.87 | +3.1% |
Agree with Wood? Disagree? Make the call yourself. It's locked at the market price and graded against the S&P 500, same as this.
Join freeNot the fund's real return: a 13F is a quarter-end snapshot of long US positions, filed up to 45 days later, and leaves out shorts, options, cash and non-US holdings. The fund may have traded since. For informational and educational purposes only. Not financial advice. Scores are opinions, not recommendations.